use of one of the available models is necessary for the assessment of the capacity of in vivo hepatic drug metabolism processes ( i.e . hepatic intrinsic clearance ) and for predicting the effect of increasing dose on blood concentrations of high clearance drugs exhibiting michaelis-menten elimination kinetics , especially those that undergo a nonlinear hepatic first-pass effect .
C0025519
metabolism
C0221102
elimination